Biocon Biologics India Limited — Trastuzumab Exporter Profile
Indian Pharmaceutical Exporter · #2 for Trastuzumab · $1.9M export value · DGFT Verified
Biocon Biologics India Limited is the #2 Indian exporter of Trastuzumab with $1.9M in export value and 39 verified shipments. Biocon Biologics India Limited holds a 2.5% market share in Trastuzumab exports across 17 countries. The company exports 5 pharmaceutical products worth $7.8M across 4 therapeutic categories.
Biocon Biologics India Limited — Trastuzumab Export Profile: Buyers & Destinations
Where Does Biocon Biologics India Limited Export Trastuzumab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $450.0K | 9 | 26.9% |
| UNITED STATES | $250.0K | 6 | 14.9% |
| SRI LANKA | $224.3K | 6 | 13.4% |
| VIETNAM | $200.0K | 4 | 11.9% |
| NETHERLANDS | $88.5K | 2 | 5.3% |
| MALAYSIA | $50.0K | 2 | 3.0% |
| SAUDI ARABIA | $50.0K | 2 | 3.0% |
| BRAZIL | $50.0K | 1 | 3.0% |
| TAIWAN | $50.0K | 1 | 3.0% |
| PARAGUAY | $50.0K | 1 | 3.0% |
Biocon Biologics India Limited exports Trastuzumab to 18 countries. The largest destination is PHILIPPINES accounting for 26.9% of Biocon Biologics India Limited's Trastuzumab shipments, followed by UNITED STATES (14.9%) and SRI LANKA (13.4%). These destinations reflect Biocon Biologics India Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Trastuzumab from Biocon Biologics India Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BIOCON BIOLOGICS UK LIMITED | BRAZIL | $688.5K | 15 |
| XXOSIXXLARXXNEWXX LIXXTED | UNITED STATES | $308.3K | 7 |
| RV HEALTH CARE PTE LTD | VIETNAM | $200.0K | 4 |
| MEDMART PHARMA (PVT) LTD | SRI LANKA | $174.3K | 5 |
| XXOCOXXBIOXXGICXXUK XXMITXX | IRELAND | $154.8K | 4 |
| XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX | SAUDI ARABIA | $50.0K | 2 |
| BANK OF CEYLON CORPORATE BRANCH | SRI LANKA | $50.0K | 1 |
| GETZ PHARMA PVT LTD | PAKISTAN | $50.0K | 1 |
| BIOCON BIOLOGICS INC | UNITED STATES | $9 | 1 |
| XXUTHXXGYPXXDRUXXINDXXTRIXX CO | EGYPT | $6 | 1 |
Biocon Biologics India Limited supplies Trastuzumab to 13 buyers globally. The largest buyer is BIOCON BIOLOGICS UK LIMITED (BRAZIL), followed by XXOSIXXLARXXNEWXX LIXXTED (UNITED STATES) and RV HEALTH CARE PTE LTD (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Trastuzumab Export Value and How Much Does Biocon Biologics India Limited Contribute?
India exported $37.2M worth of Trastuzumab through 1,882 shipments from 179 suppliers to 108 countries, serving 329 buyers globally. Biocon Biologics India Limited contributes $1.9M to this total, accounting for 2.5% of India's Trastuzumab exports. Biocon Biologics India Limited ships Trastuzumab to 18 countries through 13 buyers.
What Is the Average Shipment Value for Biocon Biologics India Limited's Trastuzumab Exports?
Biocon Biologics India Limited's average Trastuzumab shipment value is $50.0K per consignment, based on 39 shipments totaling $1.9M. The largest destination is PHILIPPINES (26.9% of Biocon Biologics India Limited's Trastuzumab exports).
How Does Biocon Biologics India Limited Compare to Other Indian Trastuzumab Exporters?
Biocon Biologics India Limited ranks #2 among 179 Indian Trastuzumab exporters with a 2.5% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($25.1M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($3.8M), ZYDUS LIFESCIENCES LIMITED ($3.4M). Biocon Biologics India Limited processed 39 shipments to 17 destination countries.
What Trastuzumab Formulations Does Biocon Biologics India Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TRASTUZUMAB FOR INJECTION | $358.3K | 9 |
| OGIVRI 420 TRASTUZUMAB | $150.0K | 3 |
| OGIVRI TM 440 -TRASTUZUMAB | $100.0K | 2 |
| TRASTUZUMAB FOR INJECTION RDNA | $100.0K | 2 |
| TRASTUZUMAB FOR INJECTIONRDNA | $100.0K | 2 |
| TRASTUZUMAB FOR INJECTION(RDNA | $100.0K | 2 |
| OGIVRI TM 150 -TRASTUZUMAB | $88.5K | 2 |
| CANMAB 440 MG/VIAL TRASTUZUMAB FOR INJEC | $63.9K | 2 |
| TRASTUZUMAB LYOPHILIZED POWDER | $50.0K | 2 |
| OGIVRI TM TRASTUZUMAB | $50.0K | 1 |
Biocon Biologics India Limited exports 23 distinct Trastuzumab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TRASTUZUMAB FOR INJECTION with 9 shipments worth $358.3K.
Regulatory Requirements: Exporting Trastuzumab to Key Markets
What Biocon Biologics India Limited must comply with to export Trastuzumab to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Biocon Biologics India Limited Compare to Nearest Trastuzumab Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $3.8M | 75 | 15 | $50.0K |
| 3 | ZYDUS LIFESCIENCES LIMITED | $3.4M | 68 | 8 | $50.0K |
| 2 | BIOCON BIOLOGICS INDIA LIMITED ★ | $1.9M | 39 | 17 | $50.0K |
| 9 | NU HOSPITALS PRIVATE LIMITED | $673.7K | 62 | 1 | $10.9K |
| 10 | DR.REDDY'S LABORATORIES LTD | $450.0K | 9 | 4 | $50.0K |
Biocon Biologics India Limited ranks #2 among 179 Indian Trastuzumab exporters. Average shipment value of $50.0K compared to the market average of $208.0K. The closest competitors by value are RELIANCE LIFE SCIENCES PRIVATE LIMITED and ZYDUS LIFESCIENCES LIMITED.
Which Indian Ports Ship Trastuzumab Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 379 | 20.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 319 | 17.0% |
| BANGALORE AIR | 254 | 13.5% |
| BANGALORE ACC (INBLR4) | 186 | 9.9% |
| Bombay Air | 99 | 5.3% |
| DELHI AIR | 74 | 3.9% |
| AHEMDABAD AIR ACC (INAMD4) | 62 | 3.3% |
| Bangalore Air | 58 | 3.1% |
What Other Advanced Oncology Products Does Biocon Biologics India Limited Export?
Biocon Biologics India Limited also exports these advanced oncology products. Each links to the detailed product page.
About Biocon Biologics India Limited
Biocon Biologics India Limited exports 5 products worth $7.8M. Beyond Trastuzumab, top products include Ras, Bevacizumab, Insulin, Ustekinumab. View the complete Biocon Biologics India Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Trastuzumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Trastuzumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Biocon Biologics India Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 45 individual customs records matching Biocon Biologics India Limited exporting Trastuzumab, covering 23 formulations to 18 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 108+ countries, 329+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Trastuzumab Export Data from Biocon Biologics India Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Biocon Biologics India Limited's Trastuzumab exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Biocon Biologics India Limited
Full Company Profile →
5 products · $7.8M total trade · 4 categories
Trastuzumab Stats
Company Overview
Top Products by Biocon Biologics India Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Biocon Biologics India Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Trastuzumab. For current shipment-level data, contact TransData Nexus.